RENALYTIX PLC - AMERICAN DEPOSITARY SHARES

Commencement of trading on OTCQB in the United States

08 10月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

11 7月 2024 06:00:03 条件 Nasdaq GlobeNewswire

Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination

27 6月 2024 17:30:18 条件 Nasdaq GlobeNewswire

Medicare Issues Final Coverage Determination for kidneyintelX.dkd

14 6月 2024 06:00:11 条件 Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

15 5月 2024 06:00:14 条件 Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15

09 5月 2024 06:00:12 条件 Nasdaq GlobeNewswire

Renalytix Announces Financing with Expected Size of up to $4 Million

08 4月 2024 06:00:23 条件 Nasdaq GlobeNewswire

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

14 3月 2024 06:00:45 条件 Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024

15 2月 2024 06:00:32 条件 Nasdaq GlobeNewswire

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

09 2月 2024 08:00:49 条件 Nasdaq GlobeNewswire

New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease

10 1月 2024 06:00:50 条件 Nasdaq GlobeNewswire

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

14 11月 2023 06:00:24 条件 Nasdaq GlobeNewswire

Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14

07 11月 2023 06:00:59 条件 Nasdaq GlobeNewswire

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

06 10月 2023 06:00:19 条件 Nasdaq GlobeNewswire

Renalytix Reports Full Year Fiscal 2023 Results

28 9月 2023 06:00:50 条件 Nasdaq GlobeNewswire

Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28

25 9月 2023 06:00:40 条件 Nasdaq GlobeNewswire

Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer

07 9月 2023 06:00:27 条件 Nasdaq GlobeNewswire

Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

03 8月 2023 06:00:29 条件 Nasdaq GlobeNewswire

Renalytix Announces Middle East Distribution Agreement with Vector Pharma

21 7月 2023 06:00:08 条件 Nasdaq GlobeNewswire

Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions

07 7月 2023 06:00:47 条件 Nasdaq GlobeNewswire